TFF Pharmaceuticals: Not A Matter Of If, But When The Shares Will Run Much HigherSeeking Alpha • 03/19/21
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/11/21
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business ResultsBusiness Wire • 03/10/21
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility CollaborationPRNewsWire • 03/09/21
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine Candidate announced by GreenLight Biosciences and TFF PharmaceuticalsPRNewsWire • 03/09/21
Why Earnings Season Could Be Great for TFF Pharmaceuticals (TFFP)Zacks Investment Research • 03/08/21
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2020 Financial Results and Business Results Conference Call on March 10, 2021Business Wire • 02/24/21
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)Business Wire • 02/19/21
TFF Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect 2021 ConferenceBusiness Wire • 01/07/21
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation Powder in a Phase 1b Clinical TrialBusiness Wire • 12/15/20
TFF Pharmaceuticals to Present at the Jefferies Virtual London Healthcare ConferenceBusiness Wire • 11/12/20
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business ResultsBusiness Wire • 11/05/20
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a Collaboration, Development and License AgreementBusiness Wire • 11/05/20
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody TherapiesBusiness Wire • 11/02/20
TFF Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 5, 2020Business Wire • 10/28/20
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza VaccinesBusiness Wire • 10/27/20
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation PowderBusiness Wire • 10/20/20
TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of StockholdersBusiness Wire • 09/30/20